In people with overweight or obesity and heart disease, semaglutide cut the combined rate of heart attacks, strokes and heart deaths. Part of the weight it takes off is lean mass rather than fat. Lifting weights and eating enough protein helped keep lean mass in dieting studies, though no finished trial has tested them on these drugs. In their own trials, the pills took off less weight than the weekly shots. Microdosing for longevity has no finished trial, and the supplements we reviewed showed much smaller effects on weight.
Do They Help Beyond Weight Loss?
GLP-1 Drugs and Longevity: Beyond Weight Loss
In a large trial of people with overweight or obesity and heart disease but no diabetes, semaglutide cut major heart events by 20%. Most of the lost weight comes back after stopping. No trial has yet set out to test whether it slows aging.
Will I Lose Muscle?
GLP-1 Muscle Loss: How Much, and How to Limit It
In one major trial, about 40% of the weight lost on semaglutide was lean mass. That counts water and organs too, not just muscle. In dieting studies, lifting weights protected lean mass and protein helped a little, but no finished trial has tested either on these drugs.
The GLP-1 Muscle Drug That Builds Mass, Not Strength
Added to semaglutide, the experimental drug bimagrumab kept more lean mass, but grip strength barely moved. Muscle spasms hit 74% of people taking the higher dose on its own. None of these muscle drugs has yet shown a health benefit for people losing weight, and none is approved for that use.
How Much Protein Do I Need?
Our protein article covers people who lift weights, not GLP-1 users in particular.
How Much Protein Per Day? 1.2 to 1.6 g per kg
In pooled training trials, extra protein stopped adding lean mass at around 1.6 grams per kilogram of body weight a day. The authors call that an estimate, not a hard cutoff. Your daily total matters more than how you split it across meals. People with kidney disease are told to keep protein lower, so their number comes from a clinician.
Pill or Shot?
The GLP-1 Pill, and the Alzheimer’s Trial That Failed
The newest GLP-1 pill took about 11% off body weight in its main trial, less than the weekly shots managed in theirs. A pill also spares you the needle and the fridge. In a large trial in early Alzheimer’s disease, the semaglutide pill did not slow the disease, though some spinal fluid markers improved.
Does Microdosing Work?
GLP-1 Microdosing: What the Trials Actually Show
No finished trial has tested GLP-1 microdosing for longevity. In the trials that exist, higher doses took off more weight, and the heart and inflammation results came from full doses. The documented harm sits in the supply: FDA safety reports flagged compounded products more often than approved ones for preparation errors and contamination.
What About Supplements?
Berberine Benefits: Why It Isn’t Ozempic
Berberine lowered blood sugar and cholesterol in trials that were mostly of low quality. It is not a natural Ozempic and does not work like one. In pooled trials it took off about 2 kg, far less than GLP-1 drugs. It can also interact with other medicines.
Akkermansia Muciniphila Supplement: What Two Trials Show
The human evidence for a heat-killed form of this gut bacterium comes from small trials. In the newest, people regained about 2 kg less weight after a diet than those on placebo, and the company behind the product funded it. The best-known US product sells the live form, which did not beat placebo in a small earlier trial.
How We Check the Studies
Every verdict on this page comes from the linked article, where each claim links to its source. Before an article goes live, a separate AI verification step re-opens every citation and removes or softens any that do not hold up. Read our methodology.
This page is for educational purposes and is not medical advice. Talk to a qualified clinician before changing your health regimen, and only start, stop or change a GLP-1 drug with your prescriber.
